as of 11-20-2026 3:45pm EST
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. A majority of its revenue is generated from the Nurse and Allied Solutions segment, which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | 1.5B | IPO Year: | 2001 |
| Target Price: | $44.79 | AVG Volume (30 days): | 787.0K |
| Analyst Decision: | Hold | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.93 | EPS Growth: | 35.58 |
| 52 Week Low/High: | $14.97 - $49.62 | Next Earning Date: | 11-05-2026 |
| Revenue: | $1,988,454,000 | Revenue Growth: | 4.53% |
| Revenue Growth (this year): | 25.69% | Revenue Growth (next year): | -20.77% |
| P/E Ratio: | 11.73 | Index: | |
| Free Cash Flow: | 233.8M | FCF Growth: | +46.79% |
SEC 8-K filings with transcript text
Nov 5, 2026 · 100% conf.
1D
-9.30%
$43.30
Act: -22.90%
5D
-14.05%
$41.03
20D
-14.59%
$40.77
2 amn-ex991x20260930xearning.htm
Document
Quarterly revenue of $717 million and adjusted EBITDA of $94 million;
GAAP net income of $0.83/share and adjusted EPS of $1.16
DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2026 financial results. Financial highlights are as follows:
Dollars in millions, except per share amounts.
Q3 2026% Change Q3 2025YTD September 30, 2026% Change YTD September 30, 2025
Revenue $717.313%$2,768.940%
Gross profit $229.124%$803.839%
Net income $33.414%$116.7nm
GAAP diluted EPS $0.839%$2.93nm
Adjusted diluted EPS* $1.16199%$4.01252%
Adjusted EBITDA* $93.663%$333.185%
* See “Non-GAAP Measures” below for a discussion of our use of non-GAAP items and the table entitled “Non-GAAP Reconciliation Tables” for a reconciliation of non-GAAP items.
Business Highlights
•Third quarter revenue and earnings exceeded guidance, driven by our travel nurse and allied businesses and a labor disruption reserve release.
•Demand for travel nursing and allied strengthened further, and our strong execution drove volume up double digits over prior year and revenue growth for a third straight quarter.
•Search revenue grew 15% year over year with strength across executive search and physician permanent placement.
•Locum tenens results were on track with our expectations amid the business’s ongoing process and technology transformation.
•Our quarter-end cash balance was $256 million with a leverage ratio, calculated under the terms of our credit agreement, of 1.3x.
1
“We are encouraged by the continued growth in nursing and allied staffing. Demand strengthened during the third quarter and through October and our team is delivering for our clients through faster recruiting, automation, and around-the-clock execution. We also are making progress on improvements in our other segments,” said Cary Grace, President and Chief Executive Officer of AMN Healthcare. “Healthcare organizations increasingly want better visibility and more strategic management of their total workforce. Our strategy to bring together our talent engagement, trusted client relationships, operational expertise, and technology-enabled solutions is well-timed with the marketplace’s demands.”
Third Quarter 2026 Results
Consolidated revenue for the quarter was $717 million, a 13% increase from the prior year and a 7% increase from the prior quarter. Net income was $33 million (4.7% of revenue), or $0.83 per diluted share, compared with net income of $29 million (4.6% of revenue), or $0.76 per diluted share in the third quarter of 2025. Adjusted diluted EPS in the third quarter was $1.16 compared with $0.39 in the same quarter a year ago.
Revenue for the Nurse and Allied Solutions segment was $460 million, higher by 27% year over year and up 9% from the prior quarter, driven by core nurse and allied businesses and labor disruption reserve releases from prior events we supported. Travel nurse staffing revenue was higher by 19% year over year and up 2% sequentially. Allied division revenue increased 11% year over year and was flat sequentially. Labor disruption contributed $59 million revenue in the quarter compared to $25 million in the prior quarter and $12 million in the year-ago quarter.
The Physician and Leadership Solutions segment reported revenue of $171 million, down 4% year over year and up 4% sequentially. Locum tenens revenue was $138 million, down 5% year over year and up 6% sequentially. Interim leadership revenue was down by 5% year over year and flat sequentially. Search revenue increased 15% year over year and was down 9% sequentially.
2
Technology and Workforce Solutions segment revenue was $86 million, a decrease of 9% year over year and 1% sequentially. Language services revenue was $69 million in the quarter, down 8% from the prior year and 1% sequentially. Vendor management systems revenue was $15 million, 11% lower year over year and flat from the prior quarter.
Consolidated gross margin was 31.9%, 280 basis points higher year over year and up 130 basis points sequentially. Higher margin in the Nurse and Allied Solutions segment, driven by the labor disruption reserve release, drove the sequential improvement.
Consolidated SG&A expenses were $149 million, or 20.8% of revenue, compared with $139 million, or 21.8% of revenue, in the same quarter last year. SG&A was $147 million, or 21.9% of revenue, in the previous quarter. The year-over-year increase in SG&A expenses was primarily due to liability insurance expense and the allowance for credit losses.
Income from operations was $51 million with an operating margin of 7.0%, compared with income of $48 million and 7.5%, respectively, in the same quarter last year. Adjusted EBITDA was $94 million, a year-over-year increase of 63%. Adjusted
Nov 6, 2025 · 100% conf.
1D
-10.08%
$16.73
Act: -3.98%
5D
-14.21%
$15.97
Act: -13.65%
20D
-14.94%
$15.83
Act: -12.63%
amn-202511060001142750false00011427502025-08-072025-08-07
Date of Report (Date of earliest event reported): November 6, 2025
(Exact Name of Registrant as Specified in Charter)
Delaware001-1675306-1500476 (State or Other Jurisdiction of Incorporation)
(Commission File Number) (I.R.S. Employer Identification No.)
2999 Olympus Boulevard, Suite 300 Dallas, Texas 75019 (Address of Principal Executive Offices) Registrant’s telephone number, including area code: (866) 871-8519
(Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))
☐Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Common Stock, par value $0.01 per shareAMNNYSE
☐Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Section 2—Financial Information
Item 2.02.Results of Operations and Financial Condition.
On November 6, 2025, AMN Healthcare Services, Inc. reported its results for the fiscal quarter ended September 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. The information in this Item 2.02 and Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent as shall be expressly set forth by specific reference in such filing.
Item 9.01.Financial Statements and Exhibits.
(d) Exhibits.
99.1Press Release issued on November 6, 2025.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMN Healthcare Services, Inc.
Date: November 6, 2025By:/s/ Cary Grace Name:Cary Grace Title:Chief Executive Officer
Aug 7, 2025
amn-202508070001142750false00011427502025-08-072025-08-07
Date of Report (Date of earliest event reported): August 7, 2025
(Exact Name of Registrant as Specified in Charter)
Delaware001-1675306-1500476 (State or Other Jurisdiction of Incorporation)
(Commission File Number) (I.R.S. Employer Identification No.)
2999 Olympus Boulevard, Suite 300 Dallas, Texas 75019 (Address of Principal Executive Offices) Registrant’s telephone number, including area code: (866) 871-8519
(Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))
☐Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Common Stock, par value $0.01 per shareAMNNYSE
☐Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Section 2—Financial Information
Item 2.02.Results of Operations and Financial Condition.
On August 7, 2025, AMN Healthcare Services, Inc. reported its results for the fiscal quarter ended June 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. The information in this Item 2.02 and Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent as shall be expressly set forth by specific reference in such filing.
Item 9.01.Financial Statements and Exhibits.
(d) Exhibits.
99.1Press Release issued on August 7, 2025.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMN Healthcare Services, Inc.
Date: August 7, 2025By:/s/ Cary Grace Name:Cary Grace Title:Chief Executive Officer
See how AMN stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "AMN AMN Healthcare Services Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.